Biopharma Co. Leads Pack Of 5 IPOs Totaling $650.8M

A Cooley-steered biopharmaceutical company developing cancer therapies led a pack of five operating companies whose shares debuted in the U.S. Friday in initial public offerings that totaled $650.8 million....

Already a subscriber? Click here to view full article